[ad_1]
![[DreaMed in Business Wire] DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System](https://blog.ourcrowd.com/wp-content/uploads/2020/03/business-wire-new.jpg)
Following its previous FDA clearance for Type 1 diabetes solution, DreaMed achieves unprecedented validation of its digital endocrinologist expert-care platform.
Read more here.
[ad_2]
Source link
[DreaMed in Business Wire] DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System
LATEST STORIES
Own and operated by The Ike Lemuwa Group, LLC a Commonwealth of Virginia Limited Liability Company, USA.
Info@nigeriasmartnews.com / info@ikelemuwagroup.com
Toll-Free: 1 888 642 8433
3821 Dominion Drive Dumfries, Virginia, 22026. USA